LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 91.94 | 21.74 | 12054 | 6121 | 1.9690 | 1.1736 | MN20160310_N01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 91.94 | 21.74 | 22 | 6121 | 0.0036 | 0.0015 | MN20160310_N01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 91.94 | 21.74 | 12659 | 6121 | 2.0678 | 1.1868 | MN20160310_N01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 93.92 | 21.74 | 35 | 6070 | 0.0058 | 0.0604 | MN20160310_N01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 93.92 | 21.74 | 12086 | 6070 | 1.9911 | 1.1769 | MN20160310_N01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 93.92 | 21.74 | 35 | 6070 | 0.0058 | 0.0604 | MN20160310_N01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 93.92 | 21.74 | 12907 | 6070 | 2.1264 | 1.1946 | MN20160310_N01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 2.24 | 21.74 | 6 | 183 | 0.0327 | -0.3418 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 2.24 | 21.74 | 510 | 183 | 2.7782 | 1.7874 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 2.24 | 21.74 | 340 | 183 | 1.8521 | 1.4434 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 4.24 | 21.74 | 2 | 317 | 0.0063 | -0.4602 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 4.24 | 21.74 | 681 | 317 | 2.1430 | 1.4354 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 4.24 | 21.74 | 616 | 317 | 1.9384 | 1.3731 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 6.21 | 21.74 | 3 | 392 | 0.0077 | -0.3779 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 6.21 | 21.74 | 795 | 392 | 2.0281 | 1.3693 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 6.21 | 21.74 | 826 | 392 | 2.1071 | 1.3912 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 8.19 | 21.74 | 9 | 439 | 0.0205 | -0.1839 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 8.19 | 21.74 | 838 | 439 | 1.9052 | 1.3203 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 8.19 | 21.74 | 927 | 439 | 2.1075 | 1.3749 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 10.16 | 21.74 | 10 | 463 | 0.0216 | -0.1613 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 10.16 | 21.74 | 880 | 463 | 1.8980 | 1.3124 | MN20160310_N01 | E21 |